Drug intelligence / Profile preview

Triaminic Thin Strips

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral
01

Overview

Triaminic Thin Strips are a line of over-the-counter (OTC) pediatric medications developed by Novartis, specifically designed as oral disintegrating films (thin strips) that dissolve on the tongue. Launched in 2004, these products are intended for children aged 4 and older to relieve symptoms of the common cold, flu, and respiratory allergies. The product line includes several formulations: the Day Time Cold & Cough version combines dextromethorphan (a cough suppressant) and phenylephrine (a nasal decongestant); the Cough & Runny Nose version contains diphenhydramine (an antihistamine); and the Night Time Cold & Cough version combines diphenhydramine and phenylephrine. These small molecule drugs work by targeting specific receptors to suppress cough, reduce nasal congestion, and alleviate allergic symptoms like runny nose and sneezing.

Brand names
Triaminic Thin Strips
02

Targets

ADRA1A (α1A)SIGMAR1 (Sigma non-opioid intracellular receptor 1)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on Triaminic Thin Strips.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triaminic Thin Strips.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call